- Home
- STGW vs CERT Comparison
STGW vs CERT Comparison
Compare STGW & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STGW
- CERT
- Stock Information
- Founded
- STGW 1980
- CERT 2008
- Country
- STGW United States
- CERT United States
- Employees
- STGW N/A
- CERT N/A
- Industry
- STGW
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- STGW
- CERT Technology
- Exchange
- STGW Nasdaq
- CERT Nasdaq
- Market Cap
- STGW 1.4B
- CERT 1.4B
- IPO Year
- STGW N/A
- CERT 2020
- Fundamental
- Price
- STGW $5.00
- CERT $8.16
- Analyst Decision
- STGW Buy
- CERT Buy
- Analyst Count
- STGW 6
- CERT 9
- Target Price
- STGW $8.46
- CERT $14.50
- AVG Volume (30 Days)
- STGW 5.1M
- CERT 2.3M
- Earning Date
- STGW 11-06-2025
- CERT 11-06-2025
- Dividend Yield
- STGW N/A
- CERT N/A
- EPS Growth
- STGW 1954.71
- CERT N/A
- EPS
- STGW 0.06
- CERT 0.07
- Revenue
- STGW $2,890,264,000.00
- CERT $415,551,000.00
- Revenue This Year
- STGW $4.18
- CERT $11.70
- Revenue Next Year
- STGW $9.16
- CERT $8.03
- P/E Ratio
- STGW $87.40
- CERT $120.93
- Revenue Growth
- STGW 6.75
- CERT 11.47
- 52 Week Low
- STGW $4.03
- CERT $8.13
- 52 Week High
- STGW $8.18
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- STGW 49.83
- CERT 22.17
- Support Level
- STGW $4.70
- CERT $8.14
- Resistance Level
- STGW $6.88
- CERT $8.91
- Average True Range (ATR)
- STGW 0.33
- CERT 0.62
- MACD
- STGW 0.02
- CERT -0.34
- Stochastic Oscillator
- STGW 17.33
- CERT 0.84
About STGW Stagwell Inc.
Stagwell Inc is the challenger holding company built to transform marketing. It delivers scaled creative performance for the world's ambitious brands, connecting culture-moving creativity with a technology to harmonize the art and science of marketing. The company's segments include Integrated Agencies Network; Brand Performance Network; and Communications Network. It generates maximum revenue from the Integrated Agencies Network segment. Geographically, it derives a majority of its revenue from the United States.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.